Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy, Safety and Efficiency of the nMARQ Pulmonary Vein Isolation System in the Treatment of Paroxysmal Atrial Fibrillation - A Pilot Study

NCT02268539 is registered in ClinicalTrials.gov with Mid and South Essex NHS Foundation Trust as lead sponsor.

NCT NCT02268539
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02268539 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy, Safety and Efficiency of the nMARQ Pulmonary Vein Isolation System in the Treatment of Paroxysmal Atrial Fibrillation - A Pilot Study
Lead sponsor
Mid and South Essex NHS Foundation Trust
Phase
Not applicable
Overall status
Completed
Start date
February 1, 2014
Completion date
December 31, 2017
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

paroxysmal atrial fibrillation